DELFLEXNeutral pH (Fresenius Medical Care North America)


Welcome to the PulseAid listing for the DELFLEX drug offered from Fresenius Medical Care North America. This Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.




LABELER NAME / MANUFACTURER: Fresenius Medical Care North America
NON-PROPRIETARY NAME: Dextrose Monohydrate, Sodium Chloride, Calcium Chloride, Magnesium Chloride, Sodium Lactate
SUBSTANCE NAME: DEXTROSE MONOHYDRATE; SODIUM CHLORIDE; SODIUM LACTATE; CALCIUM CHLORIDE; MAGNESIUM CHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
ROUTE: INTRAPERITONEAL
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1984-11-30
END MARKETING DATE: 0000-00-00


DELFLEX Neutral pH HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDELFLEX Neutral pH from Fresenius Medical Care North America
LABELER NAME: Fresenius Medical Care North America
DEA SCHEDULE:
ACTIVE STRENGTH: 1.5; 567; 353; 25.7; 15.2(g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL)
START MARKETING DATE: 1984-11-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 49230-188_369a88c0-add6-11e2-9e96-0800200c9a66
PRODUCT NDC: 49230-188
APPLICATION NUMBER: NDA018883

Other DEXTROSE MONOHYDRATE; SODIUM CHLORIDE; SODIUM LACTATE; CALCIUM CHLORIDE; MAGNESIUM CHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Baxter Healthcare CorporationDIANEAL Low Calcium with Dextrose
Fresenius Medical Care North AmericaDELFLEX